2024
All Paths Do Not Lead to Rome or Adherence: Innovative Antipsychotic Prescribing in Partnership With People in Recovery as They Define
Sebastian D, Carr E. All Paths Do Not Lead to Rome or Adherence: Innovative Antipsychotic Prescribing in Partnership With People in Recovery as They Define. Psychiatric Rehabilitation Journal 2024, 47: 303-312. PMID: 39052409, DOI: 10.1037/prj0000623.Peer-Reviewed Original ResearchShared decision-makingRecovery-oriented careExperience psychosisImplementation of shared decision-makingRecovery-oriented caring approachAntipsychotic prescribingRecovery-oriented approachInpatient psychiatric settingsCare approachPsychiatric settingsPrescribing practicesCollaborative practicePrescribingPsychiatric fieldCollaborative approachTherapeutic allianceMedicationCareAdherencePrescribed antipsychoticsPsychosisDecision-makingSymptom ameliorationAntipsychotic medicationPractice
2012
Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller BJ, Gassama B, Sebastian D, Buckley P, Mellor A. Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects. Biological Psychiatry 2012, 73: 993-999. PMID: 23062357, PMCID: PMC3816144, DOI: 10.1016/j.biopsych.2012.09.007.Peer-Reviewed Original ResearchConceptsCD4/CD8 ratioFirst-episode psychosisAcute exacerbationAntipsychotic treatmentCD8 ratioClinical statusDrug-naĂŻve first-episode psychosisTrait markerImmune cell parametersState-related markersImmune system dysfunctionCross-sectional studyPotential confounding factorsLongitudinal studyMononuclear phagocytic systemMore longitudinal studiesLymphocyte abnormalitiesTotal lymphocytesClinical featuresAntipsychotic effectsAntipsychotic medicationSystem dysfunctionBlood lymphocytesInclusion criteriaReference lists80. Meta-analysis of monocytes and lymphocytes in schizophrenia: Clinical status and antipsychotic effects
Miller B, Gassama B, Sebastian D, Buckley P, Mellor A. 80. Meta-analysis of monocytes and lymphocytes in schizophrenia: Clinical status and antipsychotic effects. Brain Behavior And Immunity 2012, 26: s22-s23. DOI: 10.1016/j.bbi.2012.07.104.Peer-Reviewed Original ResearchFirst-episode psychosisAcute psychosisAntipsychotic treatmentCD4 levelsClinical statusTrait markerCD4/CD8 ratioImmune cell abnormalitiesImmune cell parametersState-related markersCD4/CD8Potential confounding factorsEffect sizeCD8 ratioImmune dysfunctionAntipsychotic effectsAntipsychotic medicationInclusion criteriaCell abnormalitiesReference listsStable outpatientsConfounding factorsPub MedState markerMajority of studies
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply